중합효소 연쇄 반응 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)
Polymerase Chain Reaction Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032
상품코드:1492338
리서치사:Persistence Market Research
발행일:2024년 06월
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
이 조사 리포트는 세계의 중합효소 연쇄 반응(PCR) 시장을 상세 분석하고 있습니다. 이 종합적 리포트는 주요 시장 역학, 성장 촉진요인, 과제, 신규 동향에 관한 귀중한 인사이트를 제공합니다. PCR 산업의 상세 개요를 제공하고, 2024-2032년의 시장 성장 궤도를 예측하는 독점 데이터와 통계를 제시하고 있습니다.
주요 인사이트
PCR 시장 규모(2024년) : 255억 달러
예측 시장 가치(2032년) : 297억 달러
세계 시장 성장률(CAGR 2024-2032년) : 1.9%
PCR 시장 - 조사 범위 :
중합효소 연쇄 반응(PCR) 시장은 정확하고 효율적인 DNA 증폭 및 분석에 대한 헬스케어, 생명공학 및 법의학 분야 수요 증가에 힘입어 강력한 성장세를 보이고 있습니다. 이 시장은 학술 및 연구 기관, 병원, 진단 실험실, 제약 및 생명공학 기업, 법의학 연구소에 다양한 용도의 PCR 장비, 시약 및 소프트웨어 솔루션을 제공하고 있으며, PCR은 유전자 연구, 임상 진단, 질병 검출, 의약품 개발 및 법의학 분석에서 중요한 역할을 하고 있습니다. 특정 DNA 염기서열을 고정밀도와 고감도로 증폭할 수 있습니다. 시장 성장의 원동력은 PCR 기술의 발전, 감염성 및 유전성 질환의 유병률 증가, 임상 및 연구 현장에서의 PCR 채택 증가입니다.
시장 성장 촉진요인 :
세계 PCR 시장은 몇 가지 주요 성장 촉진요인의 혜택을 받고 있습니다. COVID-19를 포함한 감염성 질환의 발병률 증가는 정확하고 신속한 병원체 검출을 위한 PCR 기반 진단 테스트에 대한 수요를 촉진합니다. 또한 디지털 PCR, 실시간 PCR(qPCR), 멀티플렉스 PCR과 같은 PCR 기술의 발전은 높은 처리량, 정량적, 다중 표적의 동시 분석을 가능하게하여 진단 및 연구 능력을 향상시킬 수 있습니다. 또한 맞춤형 의료 및 분자진단에 대한 관심이 높아지면서 유전자 검사, 종양학, 약물유전체학 분야에서 PCR의 채택을 촉진하고 시장 확장을 촉진하고 있습니다. 생명과학 연구에 대한 투자 증가는 의료 인프라 및 질병 감시를 강화하기 위한 정부 구상과 결합하여 시장 성장을 더욱 촉진하고 있습니다.
시장 성장 억제요인 :
유망한 성장 전망에도 불구하고 PCR 시장은 비용, 기술적 복잡성 및 규제 준수에 대한 문제에 직면해 있으며, PCR 장비 및 시약의 높은 비용으로 인해 특히 자원이 부족한 환경과 신흥 시장에서 도입이 제한될 수 있습니다. 또한 프라이머 설계, 증폭 효율, 오염 위험과 같은 기술적 문제는 PCR 결과의 정확성과 신뢰성에 영향을 미칠 수 있으며, 전문 지식과 엄격한 품질관리 조치가 필요합니다. 또한 임상 및 진단용 규제 요건과 국제 표준 준수는 시장 진출기업에게 도전이 될 수 있으며, 제품 개발, 승인 및 상용화 일정에 영향을 미칠 수 있습니다. 이러한 장벽을 극복하기 위해서는 R&D, 교육 및 품질 보증에 대한 투자를 통해 제품 성능을 향상시키고 비용을 절감하며 규제 표준을 준수할 수 있도록 해야 합니다.
시장 기회 :
PCR 시장은 기술 혁신, 시장 다각화, 용도 확대로 인해 큰 성장 기회를 제공합니다. 나노포어 시퀀싱, 마이크로플루이딕스학, 랩온칩 장비와 같은 차세대 PCR 기술의 개발은 PCR 워크플로우의 소형화, 자동화 및 통합을 가능하게 하여 처리량, 민감도 및 사용 편의성을 향상시킬 것입니다. 또한 현장진단(POC) 진단 및 신속 검사 솔루션에 대한 수요 증가는 원격지 및 자원이 제한된 환경에서 분산형 검사에 대한 필요성을 충족시키고, 휴대용 및 현장 배치가 가능한 PCR 시스템에 대한 기회를 창출합니다. 또한 전략적 파트너십, 합병 및 인수는 시장 진입, 제품 다각화 및 지역 확장을 촉진하여 기업이 세계 PCR 환경의 새로운 트렌드와 시장 기회를 활용할 수 있도록 돕습니다.
목차
제1장 주요 요약
제2장 시장 개요
시장 범위/분류
시장의 정의/범위/제한
제3장 시장 배경
시장 역학
시나리오 예측
기회 맵 분석
투자 실현 가능성 매트릭스
PESTLE과 Porter의 산업 분석
규제 상황
제4장 세계의 중합효소 연쇄 반응 시장 분석
과거 시장 규모(금액) 분석, 2019-2023년
현재 및 향후 시장 규모(금액) 예측, 2024-2032년
전년대비 성장 동향 분석
절대적 매출 기회 분석
제5장 세계의 중합효소 연쇄 반응 시장 분석 : 유형별
서론/주요 조사 결과
과거 시장 규모(금액) 분석, 2019-2023년
현재 및 향후 시장 규모(금액) 분석과 예측, 2024-2032년
기존 PCR
기타 유형
전년대비 성장 동향 분석, 2019-2023년
절대적 매출 기회 분석, 2024-2032년
제6장 세계의 중합효소 연쇄 반응 시장 분석 : 제품 유형별
서론/주요 조사 결과
과거 시장 규모(금액) 분석, 2019-2023년
현재 및 향후 시장 규모(금액) 분석과 예측, 2024-2032년
소모품과 시약
기기
소프트웨어와 서비스
전년대비 성장 동향 분석, 2019-2023년
절대적 매출 기회 분석, 2024-2032년
제7장 세계의 중합효소 연쇄 반응 시장 분석 : 용도별
서론/주요 조사 결과
과거 시장 규모(금액) 분석, 2019-2023년
현재 및 향후 시장 규모(금액) 분석과 예측, 2024-2032년
의료
임상
연구
법의학·기타
비의료
식품
기타 비의료
전년대비 성장 동향 분석, 2019-2023년
절대적 매출 기회 분석, 2024-2032년
제8장 중합효소 연쇄 반응 시장 분석 : 지역별
서론
과거 시장 규모(금액) 분석, 2019-2023년
현재 시장 규모(금액) 분석과 예측, 2024-2032년
북미
라틴아메리카
유럽
동아시아
남아시아
오세아니아
중동 및 아프리카
지역별 시장의 매력 분석
제9장 북미의 중합효소 연쇄 반응 시장 분석(국가별)
제10장 라틴아메리카의 중합효소 연쇄 반응 시장 분석(국가별)
제11장 유럽의 중합효소 연쇄 반응 시장 분석(국가별)
제12장 동아시아의 중합효소 연쇄 반응 시장 분석(국가별)
제13장 남아시아의 중합효소 연쇄 반응 시장 분석(국가별)
제14장 오세아니아의 중합효소 연쇄 반응 시장 분석(국가별)
제15장 중동 및 아프리카 중합효소 연쇄 반응 시장 분석(국가별)
제16장 주요 국가의 중합효소 연쇄 반응 시장 분석
미국
캐나다
브라질
멕시코
아르헨티나
독일
이탈리아
프랑스
영국
스페인
러시아
베네룩스
중국
일본
한국
인도
태국
말레이시아
인도네시아
호주
뉴질랜드
GCC 국가
제17장 시장 구조 분석
경쟁 대시보드
경쟁 벤치마킹
주요 기업의 시장 점유율 분석
제18장 경쟁 분석
경쟁의 상세
Abbott
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd.
Bio-Rad Laboratories Inc.
QIAGEN NV
bioMerieux SA
Standard BioTools Inc.
Sysmex Inostics
Eppendorf AG
Danaher Corporation
Cytiva
Stilla Technologies
Microsynth AG
MatMaCorp
JN Medsys
PCR Biosystems
제19장 사용되는 전제 조건과 두자어
제20장 조사 방법
KSA
영문 목차
영문목차
Persistence Market Research, a leading market research firm, has conducted an in-depth analysis of the global Polymerase Chain Reaction (PCR) Market. This comprehensive report provides valuable insights into key market dynamics, growth drivers, challenges, and emerging trends. It offers a detailed overview of the PCR industry, presenting exclusive data and statistics projecting the market's growth trajectory from 2024 to 2032.
Key Insights:
PCR Market Size (2024): US$ 25.5 Bn
Projected Market Value (2032): US$ 29.7 Bn
Global Market Growth Rate (CAGR 2024 to 2032): 1.9%
PCR Market - Report Scope:
The Polymerase Chain Reaction (PCR) Market is experiencing robust growth, driven by increasing demand from the healthcare, biotechnology, and forensic science sectors for precise and efficient DNA amplification and analysis. This market serves academic and research institutions, hospitals and diagnostic laboratories, pharmaceutical and biotechnology companies, and forensic laboratories, offering a range of PCR instruments, reagents, and software solutions for various applications. PCR plays a critical role in genetic research, clinical diagnostics, disease detection, drug development, and forensic analysis, enabling the amplification of specific DNA sequences with high accuracy and sensitivity. Market growth is fueled by advancements in PCR technology, rising prevalence of infectious diseases and genetic disorders, and increasing adoption of PCR in clinical and research settings.
Market Growth Drivers:
The global PCR Market benefits from several key growth drivers. The rising incidence of infectious diseases, including COVID-19, drives demand for PCR-based diagnostic tests for accurate and rapid pathogen detection. Additionally, advancements in PCR technology, such as digital PCR, real-time PCR (qPCR), and multiplex PCR, enable high-throughput, quantitative, and simultaneous analysis of multiple targets, enhancing diagnostic and research capabilities. Moreover, the increasing focus on personalized medicine and molecular diagnostics fuels the adoption of PCR in genetic testing, oncology, and pharmacogenomics, driving market expansion. The growing investment in life sciences research, coupled with government initiatives to enhance healthcare infrastructure and disease surveillance, further supports market growth.
Market Restraints:
Despite its promising growth prospects, the PCR Market faces challenges related to cost, technical complexities, and regulatory compliance. The high cost of PCR instruments and reagents may limit adoption, particularly in resource-constrained settings and emerging markets. Additionally, technical challenges, such as primer design, amplification efficiency, and contamination risks, may impact the accuracy and reliability of PCR results, requiring specialized expertise and stringent quality control measures. Furthermore, regulatory requirements and compliance with international standards for clinical and diagnostic applications pose challenges for market participants, impacting product development, approval, and commercialization timelines. Addressing these barriers requires investment in research and development, training, and quality assurance to enhance product performance, reduce costs, and ensure compliance with regulatory standards.
Market Opportunities:
The PCR Market presents significant growth opportunities driven by technological innovations, market diversification, and application expansion. The development of next-generation PCR technologies, such as nanopore sequencing, microfluidics, and lab-on-a-chip devices, enables miniaturization, automation, and integration of PCR workflows, enhancing throughput, sensitivity, and ease of use. Moreover, the growing demand for point-of-care (POC) diagnostics and rapid testing solutions creates opportunities for portable and field-deployable PCR systems, addressing the need for decentralized testing in remote and resource-limited settings. Furthermore, strategic partnerships, mergers, and acquisitions facilitate market entry, product diversification, and geographic expansion, enabling companies to capitalize on emerging trends and market opportunities in the global PCR landscape.
Competitive Intelligence and Business Strategy:
Leading players in the global PCR Market, including [Insert Key Companies], focus on innovation, product differentiation, and market expansion to gain a competitive edge. These companies invest in research and development to develop next-generation PCR instruments, reagents, and software solutions, explore new applications and markets, and enhance product performance and user experience. Collaborations with academic and research institutions, diagnostic laboratories, and biotechnology companies enable companies to gain insights into market trends, customer needs, and regulatory developments, driving product innovation and market adoption. Moreover, emphasis on quality assurance, supply chain management, and customer support enhances brand reputation and customer trust in the competitive landscape of PCR technologies and solutions.
Key Companies Profiled:
Abbott
Thermo Fisher Scientific Inc.
F. Hoffmann- La Roche Ltd.
Bio-Rad Laboratories Inc.
QIAGEN N.V.
bioMerieux SA
Standard BioTools Inc.
Sysmex Inostics
Eppendorf AG
Danaher Corporation
Cytiva
Stilla Technologies
Microsynth AG
MatMaCorp
JN Medsys
PCR Biosystems
PCR Market Research Segmentation:
By Type
Conventional PCR
Other Types
By Product Type
Consumables & Reagents
Instruments
Software & Services
By Application
Medical
Clinical
Research
Forensic and others
Non-Medical
Food
Other Non-Medicals
By Region
North America
The US
Canada
The Asia Pacific
China
Japan
South Korea
India
Europe
Germany
UK
France
Russia
Italy
The Middle East and Africa
South Africa
Saudi Arabia
UAE
Nigeria
Egypt
Latin America
Mexico
Brazil
Argentina
Colombia
Table of Contents
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter's Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
4. Global Polymerase Chain Reaction Market Analysis 2019-2023 and Forecast, 2024-2032
4.1. Historical Market Size Value (US$ Bn) Analysis, 2019-2023
4.2. Current and Future Market Size Value (US$ Bn) Projections, 2024-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Polymerase Chain Reaction Market Analysis 2019-2023 and Forecast 2024-2032, By Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Bn) Analysis By Type, 2019-2023
5.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Type, 2024-2032
5.3.1. Conventional PCR
5.3.2. Other Types
5.4. Y-o-Y Growth Trend Analysis By Type, 2019-2023
5.5. Absolute $ Opportunity Analysis By Type, 2024-2032
6. Global Polymerase Chain Reaction Market Analysis 2019-2023 and Forecast 2024-2032, By Product Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Bn) Analysis By Product Type, 2019-2023
6.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Product Type, 2024-2032
6.3.1. Consumables & Reagents
6.3.2. Instruments
6.3.3. Software & Services
6.4. Y-o-Y Growth Trend Analysis By Product Type, 2019-2023
6.5. Absolute $ Opportunity Analysis By Product Type, 2024-2032
7. Global Polymerase Chain Reaction Market Analysis 2019-2023 and Forecast 2024-2032, By Application
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Bn) Analysis By Application, 2019-2023
7.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Application, 2024-2032
7.3.1. Medical
7.3.1.1. Clinical
7.3.1.2. Research
7.3.1.3. Forensic and others
7.3.2. Non-Medical
7.3.2.1. Food
7.3.2.2. Other Non-Medicals
7.4. Y-o-Y Growth Trend Analysis By Application, 2019-2023
7.5. Absolute $ Opportunity Analysis By Application, 2024-2032
8. Global Polymerase Chain Reaction Market Analysis 2019-2023 and Forecast 2024-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Bn) Analysis By Region, 2019-2023
8.3. Current Market Size Value (US$ Bn) Analysis and Forecast By Region, 2024-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. East Asia
8.3.5. South Asia
8.3.6. Oceania
8.3.7. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Polymerase Chain Reaction Market Analysis 2019-2023 and Forecast 2024-2032, By Country
9.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
9.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2032
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Type
9.2.3. By Product Type
9.2.4. By Application
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Type
9.3.3. By Product Type
9.3.4. By Application
9.4. Key Takeaways
10. Latin America Polymerase Chain Reaction Market Analysis 2019-2023 and Forecast 2024-2032, By Country
10.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
10.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Argentina
10.2.1.4. Rest of Latin America
10.2.2. By Type
10.2.3. By Product Type
10.2.4. By Application
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Type
10.3.3. By Product Type
10.3.4. By Application
10.4. Key Takeaways
11. Europe Polymerase Chain Reaction Market Analysis 2019-2023 and Forecast 2024-2032, By Country
11.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
11.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. Italy
11.2.1.3. France
11.2.1.4. U.K.
11.2.1.5. Spain
11.2.1.6. Russia
11.2.1.7. BENELUX
11.2.1.8. Rest of Europe
11.2.2. By Type
11.2.3. By Product Type
11.2.4. By Application
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Type
11.3.3. By Product Type
11.3.4. By Application
11.4. Key Takeaways
12. East Asia Polymerase Chain Reaction Market Analysis 2019-2023 and Forecast 2024-2032, By Country
12.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
12.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Type
12.2.3. By Product Type
12.2.4. By Application
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Type
12.3.3. By Product Type
12.3.4. By Application
12.4. Key Takeaways
13. South Asia Polymerase Chain Reaction Market Analysis 2019-2023 and Forecast 2024-2032, By Country
13.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
13.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2032
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Thailand
13.2.1.3. Malaysia
13.2.1.4. Indonesia
13.2.1.5. Rest of South Asia
13.2.2. By Type
13.2.3. By Product Type
13.2.4. By Application
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Type
13.3.3. By Product Type
13.3.4. By Application
13.4. Key Takeaways
14. Oceania Polymerase Chain Reaction Market Analysis 2019-2023 and Forecast 2024-2032, By Country
14.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
14.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2032
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Type
14.2.3. By Product Type
14.2.4. By Application
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Type
14.3.3. By Product Type
14.3.4. By Application
14.4. Key Takeaways
15. MEA Polymerase Chain Reaction Market Analysis 2019-2023 and Forecast 2024-2032, By Country
15.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
15.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2032
15.2.1. By Country
15.2.1.1. GCC
15.2.1.2. Rest of MEA
15.2.2. By Type
15.2.3. By Product Type
15.2.4. By Application
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Type
15.3.3. By Product Type
15.3.4. By Application
15.4. Key Takeaways
16. Key Countries Polymerase Chain Reaction Market Analysis
16.1. U.S.
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2023
16.1.2.1. By Type
16.1.2.2. By Product Type
16.1.2.3. By Application
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2023
16.2.2.1. By Type
16.2.2.2. By Product Type
16.2.2.3. By Application
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2023
16.3.2.1. By Type
16.3.2.2. By Product Type
16.3.2.3. By Application
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2023
16.4.2.1. By Type
16.4.2.2. By Product Type
16.4.2.3. By Application
16.5. Argentina
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2023
16.5.2.1. By Type
16.5.2.2. By Product Type
16.5.2.3. By Application
16.6. Germany
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2023
16.6.2.1. By Type
16.6.2.2. By Product Type
16.6.2.3. By Application
16.7. Italy
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2023
16.7.2.1. By Type
16.7.2.2. By Product Type
16.7.2.3. By Application
16.8. France
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2023
16.8.2.1. By Type
16.8.2.2. By Product Type
16.8.2.3. By Application
16.9. U.K.
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2023
16.9.2.1. By Type
16.9.2.2. By Product Type
16.9.2.3. By Application
16.10. Spain
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2023
16.10.2.1. By Type
16.10.2.2. By Product Type
16.10.2.3. By Application
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2023
16.11.2.1. By Type
16.11.2.2. By Product Type
16.11.2.3. By Application
16.12. BENELUX
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2023
16.12.2.1. By Type
16.12.2.2. By Product Type
16.12.2.3. By Application
16.13. China
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2023
16.13.2.1. By Type
16.13.2.2. By Product Type
16.13.2.3. By Application
16.14. Japan
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2023
16.14.2.1. By Type
16.14.2.2. By Product Type
16.14.2.3. By Application
16.15. South Korea
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2023
16.15.2.1. By Type
16.15.2.2. By Product Type
16.15.2.3. By Application
16.16. India
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2023
16.16.2.1. By Type
16.16.2.2. By Product Type
16.16.2.3. By Application
16.17. Thailand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2023
16.17.2.1. By Type
16.17.2.2. By Product Type
16.17.2.3. By Application
16.18. Malaysia
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2023
16.18.2.1. By Type
16.18.2.2. By Product Type
16.18.2.3. By Application
16.19. Indonesia
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2023
16.19.2.1. By Type
16.19.2.2. By Product Type
16.19.2.3. By Application
16.20. Australia
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2023
16.20.2.1. By Type
16.20.2.2. By Product Type
16.20.2.3. By Application
16.21. New Zealand
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2023
16.21.2.1. By Type
16.21.2.2. By Product Type
16.21.2.3. By Application
16.22. GCC Countries
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2023
16.22.2.1. By Type
16.22.2.2. By Product Type
16.22.2.3. By Application
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Type
17.3.3. By Product Type
17.3.4. By Application
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Abbott
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. Thermo Fisher Scientific Inc.
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. F. Hoffmann- La Roche Ltd.
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. Bio-Rad Laboratories Inc.
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. QIAGEN N.V.
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. bioMerieux SA
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
18.1.7. Standard BioTools Inc.
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.7.5.2. Product Strategy
18.1.7.5.3. Channel Strategy
18.1.8. Sysmex Inostics
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.8.5.2. Product Strategy
18.1.8.5.3. Channel Strategy
18.1.9. Eppendorf AG
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.9.5.2. Product Strategy
18.1.9.5.3. Channel Strategy
18.1.10. Danaher Corporation
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.10.5.2. Product Strategy
18.1.10.5.3. Channel Strategy
18.1.11. Cytiva
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.11.5.2. Product Strategy
18.1.11.5.3. Channel Strategy
18.1.12. Stilla Technologies
18.1.12.1. Overview
18.1.12.2. Product Portfolio
18.1.12.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.12.4. Sales Footprint
18.1.12.5. Strategy Overview
18.1.12.5.1. Marketing Strategy
18.1.12.5.2. Product Strategy
18.1.12.5.3. Channel Strategy
18.1.13. Microsynth AG
18.1.13.1. Overview
18.1.13.2. Product Portfolio
18.1.13.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.13.4. Sales Footprint
18.1.13.5. Strategy Overview
18.1.13.5.1. Marketing Strategy
18.1.13.5.2. Product Strategy
18.1.13.5.3. Channel Strategy
18.1.14. MatMaCorp
18.1.14.1. Overview
18.1.14.2. Product Portfolio
18.1.14.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.14.4. Sales Footprint
18.1.14.5. Strategy Overview
18.1.14.5.1. Marketing Strategy
18.1.14.5.2. Product Strategy
18.1.14.5.3. Channel Strategy
18.1.15. JN Medsys
18.1.15.1. Overview
18.1.15.2. Product Portfolio
18.1.15.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.15.4. Sales Footprint
18.1.15.5. Strategy Overview
18.1.15.5.1. Marketing Strategy
18.1.15.5.2. Product Strategy
18.1.15.5.3. Channel Strategy
18.1.16. PCR Biosystems
18.1.16.1. Overview
18.1.16.2. Product Portfolio
18.1.16.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
